MSB 3.21% $1.13 mesoblast limited

Cell Therapy News/Articles, page-1634

  1. 332 Posts.
    lightbulb Created with Sketch. 17
    The Fool says "I think a prudent strategy would be to keep Mesoblast on a watchlist and wait for a substantial pullback in the company’s share price before making an investment decision"

    LOL, this was posted today, so the current pullback isn't the one to wait for. Shockingly bad advice in my opinion. A major pullback in price is only likely in the event of bad news, in which case why buy at all. On the flipside, with more positive news (e.g. COVID, CHF or CLBP success) the share price is unlikely to ever return here, so you won't get an entry.

    Demonstrating not much awareness, The Fool also says "Mesoblast still has a long way to go before the company will be considered to join the ASX 200 again". Yep, at least a month or 2!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.